Drug Fights African Sleeping Sickness
Posted on: Monday, 23 April 2007, 15:00 CDT
Swedish researchers have discovered a drug extensively tested against cancer might combat African sleeping sickness.
African sleeping sickness -- a disease marked by fever, headaches and sleepiness -- is caused by a parasite that's transmitted to humans through tsetse fly bites.
The parasite escapes destruction by the host immune system because it is surrounded with a coat of proteins that constantly change. But now scientists have found the parasite might have a weakness: It contains very low amounts of cytidine triphosphate, a molecule essential for cell survival.
Artur Fijolek and colleagues at Umea University have demonstrated a protein called cytidine triphosphate synthetase, which helps synthesize CTP, was inhibited by acivicin, an anti-cancer drug tested in humans and animals but now abandoned.
The researchers tested the action of the drug on mice infected with the trypanosome parasite and found the infection was suppressed for at least one month without serious side effects.
The finding raises hopes that acivicin might be effective in fighting African sleeping sickness.
The research is detailed in the Journal of Biological Chemistry.
Source: United Press International
Related Articles
- African Sleeping Sickness Control is Vital
- Supreme Court Upholds Restricting Access to Test Drugs
- Upstream Biosciences to Collaborate With Makerere University for In Vivo Testing of Its Novel Agents to Treat African Sleeping Sickness
- Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
- US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness
- Immtech Completes Enrollment in Phase III Pivotal Trial of Pafuramidine for African Sleeping Sickness
- Inhaled-Insulin Sales Approved BRs Pennington Center Tested Drug, Alternate to Injections
- China Develops Reagent for Testing Drug Resistance of Hepatitis B Virus
- Immtech Concludes African Sleeping Sickness Clinical Trial
User Comments (0)

RSS Feeds